The Impact of SKP2 Gene Expression in Chronic Myeloid Leukemia.

Hossam HodeibDina Abd El HaiMohamed A TawfikAlzahraa A AllamAhmed F SelimMohamed E SarhanAmal SelimNesreen M SabryWael MansourAmira Youssef

Published in: Genes (2022)

gene could be an additional diagnostic and an independent prognostic marker for predicting treatment responses in first-line IM-treated CML patients at an early time point (3 months).

Keyphrases

chronic myeloid leukemia
gene expression
dna methylation
genome wide
copy number
transcription factor
newly diagnosed
replacement therapy